Genomics England uses Amazon SageMaker to predict cancer subtypes and patient survival from multi-modal data
AWS Machine Learning Blog
SEPTEMBER 10, 2024
In this post, we detail our collaboration in creating two proof of concept (PoC) exercises around multi-modal machine learning for survival analysis and cancer sub-typing, using genomic (gene expression, mutation and copy number variant data) and imaging (histopathology slides) data. 2022 ) was implemented (Section 2.1).
Let's personalize your content